We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.00 | 5.00 | 7.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 31/12/2024 | 08:00 | UK RNS | London Stock Exchange Notice Cancellation - Argent Biopharma Limited |
| 16/12/2024 | 08:13 | UK RNS | Argent Biopharma Limited Additional Information for Shareholders |
| 29/11/2024 | 11:52 | ALNC |  Argent BioPharma to delist from LSE; hints at future dual US listing |
| 29/11/2024 | 07:00 | UK RNS | Argent Biopharma Limited ASX & LSE Listing Update |
| 28/11/2024 | 09:09 | UK RNS | Argent Biopharma Limited Result of AGM |
| 31/10/2024 | 07:00 | UK RNS | Argent Biopharma Limited September 2024 Quarterly Report |
| 25/10/2024 | 06:13 | UK RNS | Argent Biopharma Limited Dispatch of Annual General Meeting Documents |
| 24/10/2024 | 06:24 | UK RNS | Argent Biopharma Limited Placing to Raise A$200,000 |
| 15/10/2024 | 07:56 | UK RNS | Argent Biopharma Limited Holding(s) in Company |
| 15/10/2024 | 07:54 | UK RNS | Argent Biopharma Limited Director/PDMR Shareholding |
1 Year Argent Biopharma Chart |
Intraday Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
